Author: Ken Dropiewski

CHF Solutions Announces Launch of Aquapheresis Therapy Using Aquadex FlexFlow® System at the Baylor Scott & White Health System in Texas

EDEN PRAIRIE, Minn., Jan. 22, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announced that Texas-based health system, Baylor Scott & White Health has initiated offering aquapheresis therapy using the company’s Aquadex FlexFlow® system at its Baylor Scott & White Medical Center in Temple, Texas. “Fluid overload continues to be […]

Renowned Cardiovascular Surgeons to Lead MemorialCare Heart & Vascular Institute, Offer Patients Least Invasive Heart Valve Surgery Breakthrough

ORANGE and LOS ANGELES Counties, Calif., Jan. 23, 2020 /PRNewswire/ — Nationally renowned cardiovascular surgeons Marc Sakwa, M.D. and Jeffrey Altshuler, M.D. are bringing their leadership, surgical advancements and world-class expertise in minimally invasive heart surgery for complex heart procedures to MemorialCare Heart & Vascular Institute, continuing the expansion and development of cardiovascular care services and the legacy […]

Bardy Diagnostics™ Announces Commercial Launch of the 14-Day Carnation Ambulatory Monitor (CAM) Patch

SEATTLE, Jan. 23, 2020 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today the commercial launch of the 14-Day version of the Carnation Ambulatory Monitor (“CAM™”), the industry’s only P-wave centric™ ambulatory cardiac patch monitor and arrhythmia detection device, following recent clearance by […]

Study Finds SureFlex® Steerable Guiding Sheath has Greater Contact Force Stability for Radiofrequency Ablations

TORONTO, Jan. 23, 2020 /PRNewswire/ – A study has found that use of Baylis Medical’s SureFlex Steerable Guiding Sheath results in greater contact force stability for radiofrequency ablations in pulmonary vein isolations. Stable contact force has been linked to more effective ablations, a therapy in which radiofrequency energy is used to create a […]

JanOne Scientific Advisory Board Chair and Leading Pain Expert Featured on ABC-7 WJLA America This Week

Dr. Christopher Kevil, pioneer in nitrite based PAD treatment and Dr. Amol Soin, foremost expert is neuropathic pain, provide scientific insight on the pain relieving qualities of JanOne’s lead drug candidate Interview to be distributed nationally on all 193 Sinclair broadcasting network affiliate stations in 89 markets across the nation […]

Medtronic Receives FDA Approval for Trial Evaluating New Energy Source with Pulsed Electric Fields to Treat Atrial Fibrillation

Investigative Technology Designed to Interrupt Irregular Pathways in the Heart DUBLIN, Jan. 23, 2020 (GLOBE NEWSWIRE) —  Medtronic plc (NYSE:MDT) today announced that it received approval from the U.S. Food and Drug Administration (FDA) to proceed with an investigational device exemption (IDE) trial to evaluate the safety and effectiveness of the PulseSelect™ Pulsed Field […]

CardioFocus® Names Burke T. Barrett As Chief Executive Officer

MARLBOROUGH, Mass., Jan. 22, 2020 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), announced today that the company’s Board of Directors has promoted Burke T. Barrett to the position of Chief Executive Officer (CEO), effective January 19, 2020. Mr. Barrett previously served as CardioFocus’ President and […]

Teleflex Receives FDA Clearance for Wattson™ Temporary Pacing Guidewire

WAYNE, Pa., Jan. 22, 2020 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, today announced that it received 510(k) clearance from the U.S. Food and Drug Administration for the WattsonTM Temporary Pacing Guidewire – the first commercially available bipolar temporary […]

Abbott Reports Fourth-Quarter 2019 Results; Announces Strong Forecast for 2020

– Fourth-quarter sales growth of 7.1 percent; organic sales growth of 8.5 percent – Fourth-quarter GAAP EPS growth from continuing operations of 59.5 percent and adjusted EPS growth from continuing operations of 17.3 percent – Several businesses achieved double-digit sales growth – Forecast reflects continued top-tier sales and earnings growth […]

SEQUANA MEDICAL LAUNCHES EQUITY PLACEMENT

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION 22 January 2020, 15:50  CET Ghent, Belgium, 22 January 2020 – Sequana Medical […]